• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Funding for antibiotic research in UK may be trailing behind resistance

byMelissa McCoyandStefan Trela
July 25, 2014
in Chronic Disease, Infectious Disease, Public Health
Reading Time: 3 mins read
Of Background Image
Share on FacebookShare on Twitter

1. Out of £13.8 billion in total available research funding in the United Kingdom (UK) from 2008-2013, 0.7% (£95.0 million) of total funding was allocated to projects pertaining to antibiotic research. 

Evidence Rating Level: 3 (Average)       

Study Rundown: The rate of evolution of resistant bacteria has increased more quickly than the rate of discovery of new antibiotics with which to combat them. New antibiotics are desperately needed to battle newly resistant pathogens. This study aimed to assess whether available funding for antibiotic research in the UK has increased enough to adequately respond to this demand. Databases of agencies providing research funding in the UK were systematically searched to identify charitably and publicly funded antibiotic projects from 2008 to 2013.

This study found that of the total available research funding in the UK, bacteriology projects received 1.9% of total funding, while antibiotic research composed nearly one-third of the projects within the specialty of bacteriology or 0.7% of the total funding. Though this study provided the first assessment of charitable and public funding for bacteriology and antibiotic research in the UK, accuracy may have been compromised by reliance upon original data from the funding organizations. Based on these findings, the authors of the study suggest that current funding levels may not be enough to combat the current burden of antibiotic-resistant bacterial infections.

This study was funded by the British Society for Antimicrobial Chemotherapy.

Click to read the study, published today in The Lancet Infectious Diseases

RELATED REPORTS

Use of procalcitonin in neonatal late-onset sepsis may reduce the duration of antibiotic therapy without increase in mortality

Treatment of chronic low back pain and disc herniation with amoxicillin-clavulanate (Augmentin) may not be effective for pain control

NVIDIA and Lilly put $1B behind AI as core drug infrastructure

Relevant Reading: Outpatient antibiotic use in Europe and association with resistance: a cross-national database study

In-Depth: This study analyzed data from major UK funding organizations, the Seventh Framework Programme for Research and Technological Development (FP7) from the European Commission, and the European Union Innovative Medicines Initiative (EU IMI) to investigate the proportion of funding provided for antibiotic research from 2008-13. Research topics were categorized as: (1) tuberculosis; (2) antibiotic discovery, research and development, and mechanisms of action; (3) understanding antibiotic resistance; or (4) epidemiology of antibiotic-resistant bacteria in human being or animals. Funding data was analyzed in terms of grant value, number of grants awarded, and percentage of total grants awarded. Grants awarded in euros were converted to pounds sterling (€1=£0·86, as of Aug 20, 2013).

Of 609 projects within the specialty of bacteriology, 196 (32.2%) specifically funded antibiotic research. Out of £13.8 billion in total available research funding in the UK, £269.2 million (1.9%) funded bacteriology projects and £95.0 million (0.7%) funded antimicrobial resistance research. The Wellcome Trust provided the greatest amount of funding (£38.2 million) towards antibiotic research, whereas the Biotechnology and Biological Sciences Research Council supported the greatest number (53) of antibiotic research projects. Smaller organizations contributed a larger percentage of their total grant funding to antibiotic research, with the British Society for Antimicrobial Chemotherapy contributing the greatest percentage (80.4%, £510,064). Additionally, £181.4 million in EU funding was awarded to antibiotic research consortia based in the UK, including £96.2 million from the FP7 program and £85.2 from the EU IMI.

More from this author: Childhood tuberculosis incidence may be 25% higher than prior estimates,Adults with Asperger’s syndrome at increased risk for suicidal thoughts and behaviors,UK fails to reduce deaths of young people, Most comprehensive study to date reveals climbing worldwide obesity prevalence,Weight loss during adulthood linked with long-term cardiovascular benefits, Reduction of key risk factors could prevent 37 million deaths by 2025

Image: PD 

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.  

Tags: antibioticsresearch
Previous Post

Shift work linked to increased risk of diabetes

Next Post

No increased overall risk of systemic events with use of anti-VEGF eye treatments

RelatedReports

Obstetric scoring systems overestimate cases of severe sepsis
Emergency

Use of procalcitonin in neonatal late-onset sepsis may reduce the duration of antibiotic therapy without increase in mortality

May 28, 2026
Epidural corticosteroid injections provide only short-term radiculopathy pain relief
Chronic Disease

Treatment of chronic low back pain and disc herniation with amoxicillin-clavulanate (Augmentin) may not be effective for pain control

May 25, 2026
Tramadol use linked with increased risk of hypoglycemia hospitalizations
AI Roundup

NVIDIA and Lilly put $1B behind AI as core drug infrastructure

January 20, 2026
Gastric bypass surgery reduces cardio-metabolic risk factors
Chronic Disease

Endoscopic sinus surgery improves quality of life compared with clarithromycin and placebo in chronic rhinosinusitis

October 28, 2025
Next Post
Blindness and visual impairment decreasing worldwide

No increased overall risk of systemic events with use of anti-VEGF eye treatments

Duloxetine reduces neuropathic pain in chemotherapy patients

African-American cancer patients more likely to receive risky analgesics

Video-based behavioral intervention benefits clinical skin examinations

Pain and itch associated with histologic features of skin cancers

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • The rate of urethrocutaneous fistula following caudal and penile blocks for hypospadias repair may be similar
  • Adjuvant chemotherapy not linked to improved outcomes in localized appendiceal adenocarcinoma
  • Deep learning model improved cancer recurrence prediction for pediatric glioma using serial imaging
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.